Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Viking Therapeutics (VKTX) Return on Assets (2016 - 2025)

Viking Therapeutics' Return on Assets history spans 11 years, with the latest figure at 0.49% for Q4 2025.

  • For Q4 2025, Return on Assets fell 38.0% year-over-year to 0.49%; the TTM value through Dec 2025 reached 0.49%, down 38.0%, while the annual FY2025 figure was 0.44%, 27.0% down from the prior year.
  • Return on Assets for Q4 2025 was 0.49% at Viking Therapeutics, down from 0.3% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.1% in Q2 2024 and bottomed at 0.49% in Q4 2025.
  • The 5-year median for Return on Assets is 0.23% (2023), against an average of 0.25%.
  • The largest annual shift saw Return on Assets soared 31bps in 2024 before it crashed -38bps in 2025.
  • A 5-year view of Return on Assets shows it stood at 0.25% in 2021, then plummeted by -62bps to 0.41% in 2022, then surged by 44bps to 0.23% in 2023, then skyrocketed by 48bps to 0.12% in 2024, then crashed by -315bps to 0.49% in 2025.
  • Per Business Quant, the three most recent readings for VKTX's Return on Assets are 0.49% (Q4 2025), 0.3% (Q3 2025), and 0.2% (Q2 2025).